MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited Shares 2011-2026 | VNRX
Annual Shares VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.1 M | 81.9 M | 57.9 M | 53.8 M | 43.4 M | 39.2 M | 31.4 M | 26.4 M | 23 M | 17.7 M | 13.4 M | 10.8 M | 9.36 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 96.1 M | 9.36 M | 38.8 M |
Quarterly Shares VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 M | 104 M | 101 M | 96.1 M | 92.4 M | 82.9 M | 82.1 M | 81.9 M | 78.3 M | 78.1 M | 63.1 M | 57.9 M | 57.5 M | 53.8 M | 53.8 M | 53.8 M | 53.2 M | 52.9 M | 50.9 M | 48.6 M | 47 M | 43.4 M | 41.2 M | 41.1 M | 39.9 M | 38.9 M | 36.2 M | 35.3 M | 32.8 M | 30 M | 27.3 M | 26.5 M | 26.5 M | 26.4 M | 26.1 M | 26.1 M | 23.5 M | 23.4 M | 19.3 M | 18.8 M | 18 M | 17.9 M | 16.5 M | 14.7 M | 13.5 M | 13.4 M | 12.2 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 8.65 M | 8.65 M | 8.65 M | 8.65 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 110 M | 8.65 M | 39.2 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.82 | -4.73 % | $ 91.5 K |  USA |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
304 M | $ 117.0 | -0.96 % | $ 35.6 B | USA |
 |
Celcuity
CELC
|
39.4 M | $ 106.68 | -1.5 % | $ 4.21 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 27.61 | -1.36 % | $ 767 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 174.64 | -2.24 % | $ 8.66 B | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 13.86 | -2.43 % | $ 419 M | USA |
|
Biodesix
BDSX
|
130 M | $ 15.89 | 0.89 % | $ 2.06 B | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
1.27 M | $ 1.1 | -3.42 % | $ 1.4 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 207.28 | -1.42 % | $ 23 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 201.9 | -1.94 % | $ 144 B | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | $ 103.4 | 0.04 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
62.6 M | $ 8.7 | -0.8 % | $ 545 M | USA |
 |
DarioHealth Corp.
DRIO
|
28.4 M | $ 10.5 | -2.33 % | $ 298 M |  Israel |
 |
DexCom
DXCM
|
390 M | $ 72.61 | -1.59 % | $ 28.3 B | USA |
 |
QIAGEN N.V.
QGEN
|
223 M | - | - | $ 10.6 B |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 24.2 | -5.62 % | $ 254 M | China |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 18.39 | -1.89 % | $ 980 M | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 106.33 | -1.79 % | $ 8.77 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
80.4 M | $ 634.75 | -0.31 % | $ 51.1 B | USA |
 |
Illumina
ILMN
|
159 M | $ 129.57 | -2.5 % | $ 20.6 B | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
125 M | $ 91.1 | -1.23 % | $ 11.4 B | USA |
 |
IQVIA Holdings
IQV
|
172 M | $ 171.85 | -1.39 % | $ 29.5 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 281.58 | -1.63 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 76.74 | 0.58 % | $ 5.18 B | USA |
 |
Brainsway Ltd.
BWAY
|
31.2 M | $ 23.13 | -2.36 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
29.3 M | - | - | $ 79.8 M | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 308.65 | -1.09 % | $ 27 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 5.03 | 0.4 % | $ 466 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 9.23 | -2.84 % | $ 1.18 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
98.4 M | $ 204.95 | 2.39 % | $ 20.2 B | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.51 | -7.1 % | $ 453 M | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 10.92 | -2.06 % | $ 2.37 B | USA |
 |
Precipio
PRPO
|
1.3 M | $ 24.5 | -0.73 % | $ 31.8 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |